HOME > About LGLS > Press Release > null

null

Title LGLS's Eutropine receives KFDA approval for SGA indication
Source LG Life Sciences
Dates 2008-06-16
Content LG Life Sciences Ltd. today announced that Eutropine has received KFDA approval for SGA (Small for Gestational Age) indication.
Files
NextLG Life Sciences wins Korea New Drug Award for Technology
PrevLG Life Sciences, Agrees with Takeda to Enter Preclinical Development for Anti-Obesity Drug Candidate
list